<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Loss of Claudin-3 Expression Induces IL6/gp130/Stat3 Signaling to Promote Colon Cancer Malignancy by Hyperactivating Wnt/β-Catenin signaling</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2019-05-13">2019 May 13.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Rizwan</forename><surname>Ahmad</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="institution">University of Nebraska Medical Center</orgName>
								<address>
									<postCode>68198</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Balawant</forename><surname>Kumar</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="institution">University of Nebraska Medical Center</orgName>
								<address>
									<postCode>68198</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhimin</forename><surname>Chen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xi</forename><surname>Chen</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Division of Biostatistics</orgName>
								<orgName type="institution">University of Miami Miller School of Medicine</orgName>
								<address>
									<settlement>Miami</settlement>
									<region>FL</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dominik</forename><surname>Müller</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Pediatric Nephrology</orgName>
								<orgName type="institution">Berlin Institute of Health</orgName>
								<address>
									<settlement>Charité, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Subodh</forename><forename type="middle">M</forename><surname>Lele</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Pathology and Microbiology</orgName>
								<orgName type="institution">University of Nebraska Medical Center</orgName>
								<address>
									<postCode>68198</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">Kay</forename><surname>Washington</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Pathology, Microbiology and Immunology</orgName>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<settlement>Nashville</settlement>
									<region>TN</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Surinder</forename><forename type="middle">K</forename><surname>Batra</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="institution">University of Nebraska Medical Center</orgName>
								<address>
									<postCode>68198</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Punita</forename><surname>Dhawan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="institution">University of Nebraska Medical Center</orgName>
								<address>
									<postCode>68198</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">VA Nebraska-Western Iowa Health Care System</orgName>
								<address>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Ph. D</roleName><forename type="first">Amar</forename><forename type="middle">B</forename><surname>Singh</surname></persName>
							<email>amar.singh@unmc.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="institution">University of Nebraska Medical Center</orgName>
								<address>
									<postCode>68198</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">VA Nebraska-Western Iowa Health Care System</orgName>
								<address>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Department of Biochemistry and Molecular Biology</orgName>
								<orgName type="institution" key="instit1">University of Nebraska Medical Center</orgName>
								<orgName type="institution" key="instit2">Nebraska Medical Center</orgName>
								<address>
									<postCode>985870, 68198-5870</postCode>
									<settlement>Omaha</settlement>
									<region>NE</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Loss of Claudin-3 Expression Induces IL6/gp130/Stat3 Signaling to Promote Colon Cancer Malignancy by Hyperactivating Wnt/β-Catenin signaling</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-05-13">2019 May 13.</date>
						</imprint>
					</monogr>
					<idno type="MD5">900B40F3FF500CF25B63992FCE069AF2</idno>
					<idno type="DOI">10.1038/onc.2017.259</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Colon cancer</term>
					<term>Barrier Dysfunction</term>
					<term>Dedifferentiation</term>
					<term>Proliferation</term>
					<term>Invasion</term>
					<term>Tight Junction</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The Hyperactivated Wnt/β-catenin signaling acts as a switch to induce EMT and promote colorectal cancer.</s><s>However, due to its essential role in gut homeostasis, therapeutic targeting of this pathway has proven challenging.</s><s>Additionally, IL-6/Stat-3 signaling, activated by microbial translocation through the dysregulated mucosal barrier in colon adenomas, facilitates the adenoma to adenocarcinomas transition.</s><s>However, inter-dependence between these signaling pathways and key mucosal barrier components in regulating colon tumorigenesis and cancer progression remains unclear.</s><s>In current study, we have discovered, using a comprehensive investigative regimen, a novel and tissue specific role of claudin-3, a tight junction integral protein, in inhibiting colon cancer progression by serving as the common rheostat of Stat-3 and Wnt-signaling activation.</s><s>Loss of claudin-3 also predicted poor patient survival.</s><s>These findings however contrasted an upregulated claudin-3 expression in other cancer types and implicated role of the epigenetic regulation.</s><s>Claudin-3−/− mice revealed dedifferentiated and leaky colonic epithelium, and developed invasive adenocarcinoma when subjected to colon cancer.</s><s>Wnt-signaling Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Genetic and epigenetic aberrations drive the formation of the benign colon adenoma and its progression to adenocarcinoma.</s><s>However, recent studies have also demonstrated key role of the impaired mucosal barrier in adenoma to carcinoma transition by enabling cancer permissive and inflammatory signaling <ref type="bibr" target="#b1">(1)</ref>.</s><s>In this regard, causal role of IL-6/Stat-3 signaling in CRC progression was recently reported <ref type="bibr" target="#b2">(2)</ref>.</s><s>Moreover, deregulated epithelial barrier can also allow growth factor infiltration into the mucosa to induce receptor tyrosine kinase signaling known to promote neoplastic transformation and growth <ref type="bibr" target="#b3">(3)</ref><ref type="bibr" target="#b4">(4)</ref><ref type="bibr" target="#b5">(5)</ref>.</s><s>Notably, TJ help maintain mucosal barrier properties.</s><s>Additionally, TJ helps regulate epithelial cell differentiation and polarity, and are accordingly deregulated during neoplastic transformation of colonic epithelial cells <ref type="bibr" target="#b6">(6)</ref>.</s><s>Furthermore, Wnt/β-catenin signaling has gained particular attention, in regulating the epithelial to mesenchymal transition (EMT) to facilitate the adenoma to carcinoma transition and CRC-progression <ref type="bibr" target="#b7">(7,</ref><ref type="bibr" target="#b8">8)</ref>.</s><s>However, key regulatory mechanism/s governing the de-differentiated colonic epithelial phenotype in correlation with cancer promoting inflammatory microenvironment and its causal association with Wnt/β-catenin signaling remain largely unclear.</s><s>Thus, improved understanding of the molecular and genetic routes that help regulate inter-dependence between Wnt/β-catenin and Stat-3 signaling to facilitate CRC-progression can help enable therapeutic mechanisms for lessening cancer aggressiveness and patient death.</s></p><p><s>In current studies, we have identified claudin-3 as the highest expressed cell-adhesion protein, among prominent cell-adhesion proteins tested, in the normal colon and positive association between claudin-3 expression and colonocyte differentiation.</s><s>Similar observation by other published reports renders support to our findings <ref type="bibr" target="#b9">(9)</ref>.</s><s>Therefore, we postulated loss of colonic claudin-3 expression to deregulate mucosal barrier function and colonocyte differentiation, and therefore promote CRC-malignancy.</s><s>However, limited published studies implicate claudin-3 in CRC-progression similar to prostate and ovarian cancers <ref type="bibr" target="#b10">(10,</ref><ref type="bibr" target="#b11">11)</ref>.</s><s>Due to these inconsistencies and our hypothesis that claudin-3 loss may promote CRCmalignancy, we performed a comprehensive investigation.</s><s>Using CRC cell lines of differing tumorigenic and metastatic potential, mouse model of colon cancer and CRC patient samples, we here demonstrate a novel colon cancer suppressive role of claudin-3.</s><s>Using genetic and pharmacological manipulations, we further confirm a role for claudin-3 by regulating intratumoral Wnt/β-catenin-and IL6/gp130/Stat3-signaling pathways.</s><s>Overall, we here provide first biochemically and clinically validated evidence to support a CRCsuppressive function of claudin-3 by serving as a conjoint rheostat for regulating Stat-3 and Wnt-signaling.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Claudin-3 is the most abundant cell-adhesion moiety in normal colon, expressed predominantly by differentiated colonocytes:</s></p><p><s>A key role of TJ in regulating epithelial barrier properties, cell differentiation and polarity is established <ref type="bibr" target="#b12">(12,</ref><ref type="bibr" target="#b13">13)</ref>.</s><s>Considering the newly emerging nexus between epithelial and immune homeostasis in regulating colon carcinogenesis, we first determined relative abundance of the key cell-adhesion proteins in normal colon.</s><s>Immunoblot analysis using mice colon lysate demonstrated claudin-3 expression to be the highest compared to claudin-1, claudin-2, claudin-7, Occludin, ZO-1, E-cadherin, β-catenin and β1-integrin (p&lt;0.01;</s><s>Fig- <ref type="figure" target="#fig_0">1A</ref> and Supplementary Fig- <ref type="figure" target="#fig_0">S1A</ref>).</s><s>Immunohistochemical (IHC) analysis further demonstrated an expression gradient with predominant claudin-3 expression at the crypt top, among terminally differentiated colonocytes (Fig- <ref type="figure" target="#fig_0">1B</ref>).</s></p><p><s>We further evaluated a causal link between claudin-3 expression and colonocyte differentiation using in vitro models of colonic epithelial cell (CEC) differentiation.</s><s>In this regard, Caco-2 cells undergo spontaneous differentiation in culture or when subjected to HDACs (histone deacetylase) inhibitors <ref type="bibr" target="#b14">(14,</ref><ref type="bibr" target="#b15">15)</ref>.</s><s>Samples from both models of differentiation were examined.</s><s>We used P-27(Kip1) and α-SMA (Smooth Muscle Actin), as positive and negative markers of CEC differentiation, respectively as controls <ref type="bibr" target="#b16">(16)</ref>  <ref type="bibr" target="#b17">(17)</ref>.</s><s>A sustained increase in P-27(Kip1) expression and simultaneous decrease in α-SMA levels supported the validity of differentiation models.</s><s>Moreover, claudin-3 expression followed suit with P-27(Kip1) expression and contrasted with α-SMA levels.</s><s>In same samples, claudin-10 expression remained largely unaltered (Fig- <ref type="figure" target="#fig_0">1C-D</ref>).</s></p><p><s>Importantly, de-differentiated phenotype characterizes colon cancer cells where poorly differentiated CRC cells are highly aggressive.</s><s>Accordingly, immunoblot analysis using a panel of 14 CRC cell lines demonstrated markedly suppressed claudin-3 levels in 10 of 14 cell lines and almost undetectable expression in HCT116 and SW620 cells (Supplementary Fig- <ref type="figure" target="#fig_0">S1B</ref>).</s><s>Of note, both cell lines are poorly differentiated and highly aggressive in vivo <ref type="bibr" target="#b18">(18,</ref><ref type="bibr" target="#b19">19)</ref>.</s><s>Taken together, our data suggested a positive association of claudin-3 expression with CEC differentiation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Colonic claudin-3 expression is epigenetically regulated:</head><p><s>Cancer cells use epigenetic regulation to exert inhibitory effect upon tumor suppressive genes and/or induce synthesis of oncogenic factors <ref type="bibr" target="#b20">(20)</ref>.</s><s>Claudin-3 gene contains multiple CPG islands in its promoter <ref type="bibr" target="#b21">(21)</ref> and epigenetic regulation of claudin-3 expression, in other cancers, has been demonstrated.</s><s>We therefore asked if loss of claudin-3 expression in CRC cells is epigenetically regulated.</s><s>To determine, we subjected SW480 and SW620 cells to global demethylation using 5-aza-2'-deoxycytidine (2.5μm).</s><s>Samples were collected 72-hours post-treatment.</s><s>Notably, in our screening, SW480 cells demonstrated low and SW620 cells demonstrated almost undetectable claudin-3 expression (Supplementary Fig- <ref type="figure" target="#fig_0">S1B</ref>).</s><s>Indeed, in both cell types 5-aza treatment induced robust claudin-3 expression in dosedependent manner (Figure <ref type="figure" target="#fig_0">-1E</ref>).</s><s>These data supported epigenetic silencing as potential mechanism underlying suppressed claudin-3 expression in colon cancer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Claudin-3 loss is an early event and associates positively with CRC progression and poor patient survival:</head><p><s>To further determine if claudin-3 expression is similarly suppressed in vivo, we examined the colon of APC min mice (Supplementary Fig- <ref type="figure" target="#fig_1">S2A-B</ref>) <ref type="bibr" target="#b22">(22)</ref>.</s><s>Since normal colon harbors robust claudin-3 levels, we reasoned that immunoblotting may not suffice, with reasonable confidence, to differentiate claudin-3 expression between APC min mice and wild type (WT) mice colon lysate.</s><s>In lieu, we performed IHC which showed chronic decrease in claudin-3 expression in colon tumor specific manner (Fig- <ref type="figure" target="#fig_0">1F</ref>).</s><s>In adjacent normal crypts, claudin-3 expression was intense, membrane localized and apicolateral (versus expected apical localization).</s><s>Interestingly, the loss of lateral claudin-3 immunoreactivity preceded the loss of the apical claudin-3 in these colon tumors (Supplementary Fig- <ref type="figure" target="#fig_0">S1C-D</ref>).</s><s>Moreover, tumors deficient in claudin-3 expression still retained E-cadherin expression and thus supported potential of claudin-3 to serve as a sensitive prognostic biomarker to assess colonocyte transformation than E-cadherin (Supplementary Fig- <ref type="figure" target="#fig_1">S2F-G</ref>).</s><s>We found similar tumor specific loss of claudin-3 in mice subjected to colitis-associated cancer (CAC; AOM-DSS-induced colon cancer (Fig- <ref type="figure" target="#fig_0">1G</ref>, Supplementary Fig- <ref type="figure" target="#fig_0">S1D</ref>, -S2C-E and -G) <ref type="bibr" target="#b23">(23)</ref>.</s><s>Overall, our data demonstrated early loss of claudin-3 expression in colon cancer.</s></p><p><s>To further determine clinical significance of our observations, we determined claudin-3 expression in CRC patients and correlation with cancer progression.</s><s>Initial assessment of claudin-3 mRNA expression in a large patient cohort (&gt;250 CRC patient samples; demographics previously described <ref type="bibr" target="#b19">(19)</ref> indeed demonstrated significant decrease in claudin-3 mRNA expression in colon adenomas (P&lt;0.05).</s><s>However, this decrease was progressive as loss of claudin-3 in all stages of CRC (versus normal mucosa) was highly significant (p&lt;0.001)</s><s>(Fig- <ref type="figure" target="#fig_1">2A</ref>).</s><s>Subsequent IHC analysis of a CRC TMA (tissue microarray; 157 cores) demonstrated, similar to the mouse colon, robust apicolateral claudin-3 expression in normal colon.</s><s>However, expression and membrane localization of claudin-3 were drastically compromised in the adenocarcinomas and metastatic samples (Fig- <ref type="figure" target="#fig_1">2B</ref> and Supplementary Fig- <ref type="figure" target="#fig_2">S3A-B</ref>).</s><s>Blinded evaluation of staining intensity in normal, adenocarcinoma and metastatic CRC samples by a pathologist further confirmed significant decreases in claudin-3 expression in CRC-samples (versus normal colon, P&lt;0.0001 (Fig- <ref type="figure" target="#fig_1">2C</ref>).</s><s>We found similar decreases in claudin-3 expression in specimen from colitisassociated cancer patients (Fig- <ref type="figure" target="#fig_1">2D</ref>).</s><s>Parallel use of the same antibody in normal prostate and prostate cancer demonstrated robust increase in adenocacrcinoma versus normal tissue, and thus supported antibody specificity (Supplementary Fig- <ref type="figure" target="#fig_2">S3C</ref>).</s><s>We further examined if claudin-3 levels may also be of prognostic significance by evaluating association of claudin-3 expression with overall survival among CRC-patients.</s><s>Based upon median claudin-3 expression values, the Kaplan-Meier survival analysis indeed demonstrated a significant and positive correlation of greater claudin-3 expression with better patient survival (p&lt;0.0491)</s><s>(Fig- <ref type="figure" target="#fig_1">2E</ref>).</s><s>Taken together, we found a positive correlation between claudin-3 expression loss, CRC-progression, and poor patient survival.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Claudin-3 null (Cldn-3KO) mice demonstrate de-differentiated colonic epithelium, infiltratory immune microenvironment and aggressive tumor burden:</head><p><s>To further evaluate if claudin-3 loss is causally associated with colon tumorigenesis, we used Cldn-3KO mice (see methods).</s><s>Immunoblot analysis using mice colon lysate confirmed inhibition of claudin-3 protein synthesis in Cldn-3KO mice.</s><s>Interestingly, claudin-3 depletion did not affect colonic expression or cellular localization of claudin-1, −2 or −7 proteins, known to be altered in CRC <ref type="bibr" target="#b19">(19,</ref><ref type="bibr" target="#b24">24,</ref><ref type="bibr" target="#b25">25)</ref> (Supplementary Fig- <ref type="figure" target="#fig_3">S4A and -S4B</ref>).</s><s>Irrespective, analysis using rectal administration of FITC-Dextran (4kDa) to determine mucosal barrier dysfunction demonstrated a significant increase in mucosal leakage in Cldn-3KO mice (versus WT-mice; p&lt;0.05) (Fig- <ref type="figure" target="#fig_2">3A</ref>).</s><s>Additionally, IHC analysis using anti-CD3 antibody demonstrated marked upregulation in T-cell infiltration in naïve Cldn-3KO mice (versus WT-mice, p&lt;0.001;</s><s>Fig- <ref type="figure" target="#fig_2">3B</ref> and Supplementary Fig- <ref type="figure" target="#fig_3">S4D</ref>).</s><s>Most notably, immunoblot analysis demonstrated suppressed P-27(Kip-1) expression (p&lt;0.05) and contrasting upregulation of Vimentin, a mesenchymal cell marker, in Cldn-3KO mice colon (versus WT mice; Fig- <ref type="figure" target="#fig_2">3C</ref> and Supplementary Fig- <ref type="figure" target="#fig_3">S4C</ref>).</s><s>Taken together, our data supported an important role of claudin-3 in maintaining differentiated CEC phenotype and mucosal barrier function, and potential susceptibility of Cldn-3KO mice to colon tumorigenesis.</s></p><p><s>We further examined if loss of colonic claudin-3 expression can promote colon cancer progression.</s><s>Cldn-3KO mice were subjected to the AOM-DSS induced colon carcinogenesis.</s><s>Remarkably, Cldn-3KO mice subjected to colon cancer not only demonstrated significant body weight loss during the DSSIII cycle (p&gt;0.05;</s><s>versus WTmice; Supplementary Fig- <ref type="figure" target="#fig_4">S5A</ref>).</s><s>Also, some AOM-DSS treated Cldn-3KO mice died before the study termination (data not included).</s><s>Moreover, we observed significant increase in the colon weight (gm/cm length; p&lt;0.05) of AOM-DSS treated Cldn-3KO mice (versus WT mice; Supplementary Fig- <ref type="figure" target="#fig_4">S5B</ref>).</s><s>In corroboration, gross tumor numbers, at the study end, demonstrated significant increase (p&lt;0.01) in colon tumor burden in Cldn-3KO mice (versus WT mice; Fig- <ref type="figure" target="#fig_2">3D-E</ref>).</s><s>Further analysis revealed that the tumors in Cldn-3KO mice were not only more in number but also in size (large, intermediate and small tumors: 40%, 33% and 27% in Cldn-3KO mice versus 28%, 20% and 52% in WT mice; Fig- <ref type="figure" target="#fig_2">3F</ref>).</s><s>In accordance, Cldn-3KO mice showed significantly higher tumor score (p&lt;0.5), a recently described measure of cancer progression (26) (Fig- <ref type="figure" target="#fig_3">4A</ref>).</s><s>Most notably, 33% of Cldn-3KO mice developed invasive adenocarcinomas (p&lt;0.01)</s><s>compared to none (0%) in WT mice (Fig- <ref type="figure" target="#fig_3">4B-C</ref>).</s><s>Overall, these results uncovered a novel, and tissue specific cancer suppressing role for claudin-3 in colon cancer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Claudin-3 depletion in CRC cells induces de-differentiated phenotype and invasive mobility:</head><p><s>To further elucidate the causal role of claudin-3 in regulating CEC differentiation to inhibit cancer cell phenotype, we silenced claudin-3 expression in CRC cells using anti-human claudin-3 or control siRNA.</s><s>Immunoblotting to determine altered protein expression, wound healing and cell invasion assays were performed.</s><s>As shown in Fig- <ref type="figure" target="#fig_3">4D</ref>, immunoblot analysis demonstrated that claudin-3 depletion, similar to in vivo conditions, inhibited P-27(Kip1) expression however upregulated vimentin and cyclin-D1 expression.</s><s>Moreover, claudin-3 silenced cells demonstrated significant increases in migration (wound-healing assay) and invasion (Boyden chamber assay) (p&lt;0.05 and p&lt;0.01 respectively; versus control cells) (Fig- <ref type="figure" target="#fig_3">4E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Claudin-3 expression associates inversely with vimentin expression:</head><p><s>One of our key findings was a consistent increase in vimentin expression, a type III intermediate filament and EMT marker, under claudin-3 suppressed conditions.</s><s>In colon cancer, vimentin expression associates positively with high malignant potential and poor prognosis of colorectal patients, and is highly expressed in cancer cells at the invading front <ref type="bibr" target="#b27">(27,</ref><ref type="bibr" target="#b28">28)</ref>.</s><s>We therefore examined potential association between claudin-3 and vimentin expression in CRC patients.</s><s>Spearman's correlation analysis, using the same patient cohort utilized in the analysis described in Fig- <ref type="figure" target="#fig_1">2A</ref>, indeed demonstrated a significant inverse correlation between claudin-3 and vimentin expression in patient samples (p&lt;0.0002)</s><s>(Fig- <ref type="figure" target="#fig_3">4F</ref>).</s><s>We further examined whether this correlation is simply byproduct of the end point changes in gene expressions in cancer cells or dynamic association.</s><s>Co-immunolocalization for claudin-3 and vimentin was performed using the colon of AOM/DSS-treated WT mice.</s><s>Specific emergence of vimentin expression in tumor areas where claudin-3 expression is chronically suppressed suggested that the observed inverse correlation is dynamic and may regulate emergence of cancer invasive front (Fig- <ref type="figure" target="#fig_3">4G</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hyperactivated Wnt/β-catenin signaling, intratumoral proliferation and cancer cell survival facilitate colon cancer progression in Cldn-3KO mice:</head><p><s>To further ascertain whether increased tumor burden in Cldn-3KO mice is result of an increase in proliferation, cancer cell survival, decreased apoptosis or all combined, we determined intratumoral proliferation and apoptosis by IHC using anti-Ki-67 and -cleaved caspase-3 antibodies.</s><s>Analysis demonstrated a significant increase in proliferation/apoptosis ratio between Cldn-3KO and WT-mice mice tumors (p&lt;0.05;</s><s>Fig- <ref type="figure" target="#fig_4">5A</ref> and Supplementary Fig- <ref type="figure" target="#fig_4">S5C</ref>).</s><s>Immunoblot analysis using total colon lysate from mice subjected to colon cancer further demonstrated a significant increase in cyclin-D1 expression (p&lt;0.01), a proliferation inducer and Wnt/β-catenin-signaling target, and Bcl-2 (p&lt;0.05),</s><s>anti-apoptotic protein, in Cldn-3KO mice (versus WT-mice; Fig- <ref type="figure" target="#fig_4">5B</ref>).</s><s>These findings suggested role of the increased tumor cell proliferation/survival in CRC progression fueled by the loss of claudin-3 expression.</s></p><p><s>Notably, colon cancer regulation is a multifaceted process and involves dysregulation of multiple unique and/or overlapping pathways.</s><s>However, a recent study suggest that claudin-3 loss may promote Wnt/β-catenin-signaling, key regulator of CRC progression, to promote hepatocellular cancer <ref type="bibr" target="#b29">(29)</ref>.</s><s>Upregulation of cyclin-D1 in Cldn-3KO mice tumors (Fig- <ref type="figure" target="#fig_4">5B</ref>) or Caco-2 siRNA cells (Fig- <ref type="figure" target="#fig_3">4D</ref>) further supported potential role of Wnt/β-cateninsignaling in claudin-3 dependent CRC-progression.</s><s>Since, cytoplasmic/nuclear β-catenin expression signifies Wnt/β-catenin-signaling activation, IHC using anti-β-catenin antibody was done.</s><s>As expected, we found cytoplasmic anti-β-catenin immunoreactivity in WT-mice tumors.</s><s>However, the delocalized β-catenin expression was markedly upregulated and predominantly nuclear localized in Cldn-3KO mice colon tumors and thus suggested Wnt-βcatenin-signaling hyperactivation (Fig- <ref type="figure" target="#fig_4">5C</ref>).</s><s>Immunoblot analysis using colon lysate further revealed a significant upregulation of β-catenin levels in AOM-DSS treated Cldn-3KO mice (versus WT-mice; p&lt;0.01;</s><s>Fig- <ref type="figure" target="#fig_4">5D</ref>) suggesting potential inhibition of protein degradation.</s><s>Notably, GSK-3β regulates β-catenin expression through the regulation of its protein stability <ref type="bibr" target="#b30">(30)</ref> and inactivation of GSK-3β (by phosphorylation) reduces β-catenin ubiquitination resulting in its nuclear accumulation <ref type="bibr" target="#b31">(31)</ref>.</s><s>However, contrasting our expectation, P-GSK3β (Ser9) expression in Cldn-3KO mice was sharply decreased (versus WT-mice; p&lt;0.001), (Fig- <ref type="figure" target="#fig_4">5D</ref>).</s><s>We found similar decrease in P-GSK3β expression in Caco-2 siRNA cells (Fig- <ref type="figure" target="#fig_4">5E</ref>) suggesting a GSK-3β independent role of claudin-3 in hyperactivating Wnt-β-catenin-signaling during colon tumorigenesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Claudin-3 loss induces IL6/gp130/Stat-3 signaling:</head><p><s>As described, we found increased gut permeability (p&lt;0.05;</s><s>Fig- <ref type="figure" target="#fig_2">3A</ref>) and exacerbated immune organization (CD3+ immune cell, Fig- <ref type="figure" target="#fig_2">3B</ref>) in naïve Cldn-3KO mice colon which was further augmented in their tumors (Supplementary Fig- <ref type="figure" target="#fig_5">S6A</ref>).</s><s>Emerging studies suggest an intricate role of Stat-3 signaling in colon cancer progression by interlacing epithelial and immune homeostasis <ref type="bibr" target="#b2">(2)</ref>.</s><s>Therefore, we examined if claudin-3 loss induces Stat-3 signaling.</s><s>Immunoblot analysis using colon lysate indeed demonstrated a specific and significant (p&lt;0.001)</s><s>increase in P-Stat3(Tyr705) expression in Cldn-3KO mice subjected to colon cancer (versus WT mice; Fig- <ref type="figure" target="#fig_4">5F</ref>).</s><s>Thereafter, IHC analysis was done to determine the source of the activated Stat-3 as phosphorylation shuttles Stat-3 protein into the nucleus to initiate a transcriptional program (Supplementary Fig- <ref type="figure" target="#fig_5">S6B</ref>).</s><s>Of interest, the role of the IL-6/ Stat-3 signaling, upregulated by dysregulated barrier function in colon adenomas, in CRC progression was recently reported <ref type="bibr" target="#b2">(2)</ref>.</s><s>In concurrence, IHC analysis using anti-IL6 antibody demonstrated markedly higher immunoreactivity in Cldn-3KO versus WT mice tumors which was predominantly epithelial but also of immune cell origin (Supplementary Fig- <ref type="figure" target="#fig_5">S6C</ref>).</s><s>qRT-PCR further demonstrated significant increases in IL-6 and IL-23, protumorigenic cytokines but not in TNF-α expression in these mice (Fig- <ref type="figure" target="#fig_4">5G</ref>).</s><s>Taken together, our data suggested that claudin-3 loss induces IL-6/IL23/Stat-3 signaling to promote colon cancer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-6/gp130/Stat-3-signaling hyperactivates Wnt-signaling induction by the loss of claudin-3 expression:</head><p><s>A key finding in Caco-2 siRNA cells was the marked delocalization of the membrane expressed β-catenin, similar to the in vivo findings (Fig- <ref type="figure" target="#fig_5">6A</ref>).</s><s>Moreover, TOP-FLASH reporter activity was significantly increased (p&lt;0.001) in these cells (Fig- <ref type="figure" target="#fig_5">6B</ref>).</s><s>Additional studies where control or Caco-2 siRNA cells were cultured on transwell filter support, bathed in same culture medium apically and basolaterally, demonstrated similar upregulation of Wnt-signaling suggesting that the effect of claudin-3 loss in inducing Wnt-signaling may be direct and not necessarily dependent on the leaky barrier (Supplementary Fig- <ref type="figure">S7A-C</ref>).</s><s>We further determined if there is a cross talk between Wnt-and Stat-3 signaling in hyperactivating Wnt-signaling under claudin-3 depleted conditions.</s><s>Previous studies have demonstrated a cross talk between Wnt signaling and IL-6/STAT3 signaling and cell survival <ref type="bibr" target="#b32">(32,</ref><ref type="bibr" target="#b33">33)</ref>.</s><s>To test, we first determined if Stat-3 signaling is also activated in Caco-2 siRNA cells.</s><s>IL-6 treatment served as positive control.</s><s>Similar to the Cldn-3KO mice, we found robust P-Stat3(Tyr705) expression in Caco-2 siRNA cells which was further augmented by IL-6 treatment (Fig- <ref type="figure" target="#fig_5">6C</ref>).</s><s>Further determinations also uncovered marked increases in gp130 expression, the IL-6 receptor, in Caco-2 siRNA cells, and also in Cldn-3KO mice (Supplementary Fig- <ref type="figure" target="#fig_5">S6D-E</ref>), suggesting potential activation of IL-6/gp130/Stat-3 signaling under claudin-3 depleted condition.</s><s>Interestingly, IL-6 treatment also induced cyclin-D1 expression which again was highly upregulated in Caco-2 siRNA cells (Fig- <ref type="figure" target="#fig_5">4D and -6C</ref>), similar to Cldn-3KO mice (Fig- <ref type="figure" target="#fig_4">5B</ref>).</s><s>Cyclin-D1 is a Wnt-signaling target.</s><s>Therefore, we further determined causal association between Stat-3 signaling and Wnt/β-catenin signaling.</s><s>In this regard, IL-6 treatment exacerbated the delocalized β-catenin expression in Caco-2 siRNA cells.</s><s>In contrast, inhibiting Stat-3 signaling using Niclosamide (10 uM), a Phopsho-Stat-3 specific inhibitor, rescued the membrane localized β-catenin expression (Fig- <ref type="figure" target="#fig_5">6A</ref>).</s><s>Niclosamide treatment also inhibited TOP-FLASH reporter activity in Caco-2 siRNA cells and expression of Wnt-target genes cyclin-D1 and c-Myc (Fig- <ref type="figure" target="#fig_5">6D-E</ref>).</s><s>Taken together, our studies suggested that the loss of claudin-3 expression promotes colon cancer by modifying epithelial and immune homeostasis by serving as a common rheostat for Stat-3 and Wnt-signaling (Fig- <ref type="figure" target="#fig_5">6F</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>A highly prevalent nuclear β-catenin expression and an overactivated Wnt/β-catenin signaling in aggressive colon cancer has fueled the concept that hyperactivated Wntsignaling promotes CRC-progression, possibly by regulating the EMT switch <ref type="bibr" target="#b34">(34,</ref><ref type="bibr" target="#b35">35)</ref>.</s><s>However, Wnt-signaling is required for normal gut homeostasis and regeneration of adult intestinal epithelium, and therefore direct therapeutic targeting of this pathway to control CRC-malignancy has proven to be challenging.</s><s>Thus, current findings confirming a novel colon cancer suppressive role of claudin-3 in its capacity to avert intratumoral Wnt-signaling hyperactivation is an important step in this direction.</s><s>Our finding that the loss of claudin-3 activates Wnt-signaling which is then hyperactivated by the IL-6/gp130/Stat3 signaling further highlights the pivotal role of claudin-3 in regulating colonic epithelial and immune homeostasis.</s><s>A role for Stat-3 signaling in accelerating CRC-progression is established <ref type="bibr" target="#b1">(1,</ref><ref type="bibr" target="#b2">2,</ref><ref type="bibr" target="#b36">36)</ref>.</s><s>Also, Stat-3 dependent Wnt-signaling activation is now reported in specific neoplasms <ref type="bibr" target="#b33">(33,</ref><ref type="bibr" target="#b37">37)</ref>.</s><s>Overall, we here describe a novel role of claudin-3 in regulating CRC malignancy by serving as a common rheostat for two critical CRC-promoting signaling pathways.</s></p><p><s>Our findings however contrast an upregulated claudin-3 expression in many cancer types including the prostate, ovarian and renal cancers and thus suggest tissue specificity <ref type="bibr" target="#b11">(11,</ref><ref type="bibr" target="#b38">38,</ref><ref type="bibr" target="#b39">39)</ref>.</s><s>Our findings also contradict limited reports suggesting CRC promoting role for claudin-3 <ref type="bibr" target="#b10">(10)</ref>.</s><s>These inconsistencies necessitated comprehensive investigation to clarify the status and role of claudin-3 in colon carcinogenesis.</s><s>Accordingly, our conclusions are based upon studies utilizing a panel of CRC cells with differing tumorigenic abilities, murine models of colorectal cancer, mRNA and protein expression analysis using a large CRC patient cohort, and genetic manipulation of claudin-3 expression in vitro and in vivo in claudin-3KO mice in the context of colon tumorigenesis.</s><s>Moreover, we have confirmed the specificity of the reagents used to probe claudin-3 levels, using prostate cancer tissue where claudin-3 expression is highly upregulated.</s><s>A decrease in claudin-3 expression in APC min mice colon tumors in a recent study probing mechanisms underlying CRC progression supports our findings <ref type="bibr" target="#b1">(1)</ref>.</s><s>Additionally, inhibition of PI-3 kinase signaling in poorly differentiated HCT116 cells induced claudin-3 expression along with epithelial differentiation <ref type="bibr" target="#b40">(40)</ref>.</s><s>A similar decrease in claudin-3 expression was recently reported to promote hepatocellular carcinoma.</s><s>Moreover, promoter hypermeythylation, also observed in our studies, suppresses claudin-3 levels in hepatocellular carcinomas <ref type="bibr" target="#b29">(29)</ref>.</s><s>Interestingly, epigenetic regulation involving promoter derepression induces claudin-3 upregulation in prostate and ovarian cancers <ref type="bibr" target="#b41">(41)</ref>.</s><s>Coincidently, siRNA silencing of DNA methytransferase, DNMT-1, altered claudin-3 expression differentially between PC3 (prostate cancer cells) and Caco-2 cells, suggesting tissue-specific regulation <ref type="bibr" target="#b42">(42)</ref>.</s><s>While these data support tissuespecific epigenetic regulation of claudin-3 expression in functional correlation with cancer progression, further investigations are clearly needed for improved understanding of this differential regulation of claudin-3 in different cancer types.</s></p><p><s>Importantly, claudin family of proteins forms the "backbone" of TJ between epithelial cells <ref type="bibr" target="#b43">(43)</ref>.</s><s>While TJ maturation associates with terminal differentiation, the disassembly of TJ can lead to the loss of polarity and increased cell mobility in addition to barrier dysfunction.</s><s>However, claudin proteins are expressed in cell and tissue specific manner and therefore tissue-specific role of claudin proteins is highly probable <ref type="bibr" target="#b43">(43)</ref>.</s><s>Our data suggest that in colonic epithelium claudin-3 protein is essential to uphold the differentiated phenotype.</s><s>Our findings that claudin-3 loss was sufficient to induce colon cancer permissive microenvironment, without modulating expression of claudin-1, −2 or −7 causally associated with colon tumorigenesis, signifies its key role in colonic epithelial homeostasis <ref type="bibr" target="#b19">(19,</ref><ref type="bibr" target="#b24">24,</ref><ref type="bibr" target="#b25">25)</ref>.</s><s>Of note, colonic claudin-3 expression increases post-birth and correlates with maturity of the mucosal barrier <ref type="bibr" target="#b44">(44)</ref>.</s><s>On the other-hand, sharp decreases in claudin-3 expression associated with impaired barrier function in mice lacking the toll-like receptor adaptor protein MyD88.</s><s>Moreover, probiotic bacterial colonization in MyD88 null mice colon not only improved the barrier maturity but also colonic increased claudin-3 levels <ref type="bibr" target="#b44">(44)</ref>.</s><s>Specific loss of claudin-3 expression, among claudin proteins, also correlates with deregulated mucosal barrier in other pathological conditions of gastrointestinal tract <ref type="bibr" target="#b45">(45)</ref><ref type="bibr" target="#b46">(46)</ref><ref type="bibr" target="#b47">(47)</ref>.</s><s>Furthermore, a recent study has demonstrated specific loss of claudin-3 expression along with deregulated colonocyte differentiation in mice lacking histone deacytylases HDAC-1 and HDAC-2 in their gut epithelium <ref type="bibr" target="#b48">(48)</ref>.</s><s>Coincidentally, these mice also demonstrate increased Stat-3 activity, mucosal inflammation and colonocyte proliferation similar to Cldn-3KO mice <ref type="bibr" target="#b48">(48)</ref>.</s><s>Interestingly, claudin-3 expression is also inhibited in the colon of Stat-3 knockout mice <ref type="bibr" target="#b49">(49)</ref>.</s><s>Taken together, a complex inter-relationship between claudin-3 expression, mucosal barrier and Stat-3 signaling in regulating colonic homeostasis is plausible.</s><s>In this regard, we have documented specific increases in the expression of inflammatory cytokine IL-6 in and its receptor gp130 in claudin-3 depleted conditions.</s><s>Furthermore, upregulated P-Stat3 levels in Caco-2 siRNA cells could be upregulated by exogenous administration of IL-6.</s><s>This observation in association with our observation that P-Stat3 and IL-6 levels increase in both, epithelial and immune components in Cldn-3KO mice suggest collective contribution of epithelial and immune mechanisms in observed increases in Stat-3 signaling in Cldn-3KO mice.</s><s>The role of the IL-6/Stat-3 signaling by activating IL-17/IL-23 signaling in promoting CRC progression was recently reported (1, 2).</s><s>As described, impaired mucosal barrier in colon adenomas was found to be responsible for promoting intra-tumoral Stat-3 activation by allowing gut microbe translocation into the mucosa (1).</s><s>The Cldn-3KO mice gut is significantly leakier than littermate WT-mice.</s><s>Taken together, we postulate that the loss of claudin-3 expression dysregulates mucosal barrier function and upregulates gp130 expression, possibly in response to the altered epithelial differentiation.</s><s>Altered mucosal barrier facilitates translocation of the gut antigens into the mucosa.</s><s>Our data demonstrating significant upregulation of baseline immune cell infiltration into the colonic mucosa in Cldn-3KO versus WT-mice supports such a postulation.</s><s>Resultant activation of the immune landscape especially IL-6 synthesis accompanied with upregulated gp130 levels results in activated Stat-3 signaling.</s><s>IL-6 is an established regulator of Stat-3 signaling (50).</s><s>However, deregulated mucosal barrier can also allow infiltration of the luminal growth factors and thus allow activation of growth permissive signaling cascade, as demonstrated elegantly by Soler et.</s><s>Al. <ref type="bibr" target="#b3">(3,</ref><ref type="bibr" target="#b51">51)</ref>.</s><s>Clearly, additional studies are needed to understand global changes due to claudin-3 loss in the colonic mucosa and are currently underway using high throughput analysis.</s><s>The ongoing studies in our laboratory are also aimed at examining the molecular details of claudin-3/IL/Stat-3 regulation and its significance in mucosal inflammatory pathologies.</s></p><p><s>Another interesting observation of our study, was the finding that Wnt/β-catenin signaling was hyperactivated in Cldn-3KO mice tumors, potentially independent of GSK-3β regulation.</s><s>This conclusion is based upon multiple parameters associated with activated Wnt/β-catenin and include: 1) upregulated intratumoral nuclear β-catenin expression in Cldn-3KO mice compared to WT-mice; 2) Marked upregulation of total β-catenin expression levels in colon lysate from tumor bearing Cldn-3KO mice (versus WT-mice); 3) increased cyclin-D1 expression and proliferation/apoptosis ratio in tumor bearing Cldn-3KO mice (versus WT-mice); and 4) increased TOP-FLASH reporter activity in claudin-3 silenced CRC cells along with marked increases in Cyclin-D1, C-Myc and Ki-67 expression (versus control cells).</s><s>Our findings gain strength from similar upregulation of Wnt/β-catenin signaling and suppressed claudin-3 levels in hepatocellular carcinoma <ref type="bibr" target="#b29">(29)</ref>.</s><s>Notably, GSK-3β is a key enzyme in regulating Wnt/β-catenin signaling by stabilizing β-catenin expression as observed in our study.</s><s>Increased phosphorylation (Ser9) of GSK-3β inhibits its ability to phosphorylate β-catenin to target it for ubiquitination and degradation.</s><s>However, we have found contrasting suppression of P-GSK-3β expression in Cldn-3KO mice suggesting a different mechanism regulating β-catenin in our mouse model.</s><s>Our data that inhibiting Stat-3 activation in claudin-3 silenced CRC cells inhibited TOP-FLASH reporter activity suggest plausible role of Stat-3 signaling in promoting Wnt-signaling under conditions of the loss of colonic claudin-3 expression in the colon.</s><s>Notably, Stat-3 activation also promotes intestinal epithelial cell proliferation and Cyclin-D1 expression, a Wntsignaling target <ref type="bibr" target="#b2">(2,</ref><ref type="bibr" target="#b52">52,</ref><ref type="bibr" target="#b53">53)</ref>.</s><s>Furthermore, a cross-talk between Stat-3 activation and Wntsignaling in regulating cancer progression is documented however molecular details remain largely unexplored <ref type="bibr" target="#b37">(37)</ref>.</s><s>We predict that the loss of claudin-3 accelerates CRC progression by two distinct mechanisms: 1) by inducing Wnt-signaling and therefore EMT switch due to the loss of epithelial differentiation, and 2) by promoting intratumoral Wnt-signaling hyperactivation by activating Stat-3-signaling.</s><s>Our findings that the loss of claudin-3 in vitro or in vivo inhibits P-27/Kip-1 expression, upregulates vimentin expression, Wnt-and IL-6/ Stat-3-signaling strongly support such a postulation.</s><s>In accordance, we have found a significant correlation between claudin-3 and vimentin expression in CRC samples and mouse colon tumors.</s><s>Of interest, vimentin expression marks the invasive front in aggressive CRC samples.</s></p><p><s>Taken together, we here identify a novel and tissue-specific CRC-suppressive role of caludin-3.</s><s>The fact that loss of claudin-3 expression not only promoted dedifferentiated colonic epithelial phenotype but also promoted IL-6/Stat-3 signaling suggest its pivotal role in serving as a central regulator of EMT and inflammation, two critical facilitators of CRC malignancy.</s><s>Moreover, our data that loss of claudin-3 induces hyperactivation of Wnt/βcatenin signaling and its cross talk with Stat-3 signaling identifies this protein as an important therapeutic target in the fight against CRC.</s><s>Positive association between claudin-3 loss and poor CRC patient survival supports such a postulation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture and transfection:</head><p><s>The cell lines used in the current study were either purchased from ATCC or acquired from collaborative laboratories and have been described previously <ref type="bibr" target="#b19">(19)</ref>.</s><s>Only low cell passages were used, and the identity of cell lines used for detailed studies was routinely verified by DNA fingerprinting.</s><s>Cells were transfected with human claudin-3 specific or control siRNA or shRNA (Invitrogen, CA and Sigma-Aldrich, MO) using RNAiMAX Reagent (Invitrogen) as per manufacturer instructions.</s><s>In studies involving determination of reporter activity, cells transfected with anti-claudin-3 siRNA were replated 24 hours post siRNA transfection and re-transfected with the TOPFLASH reporter and/or control constructs.</s><s>Transfection efficiency was normalized to Renilla luciferase activity of the phRL-TK (Promega Inc.).</s><s>Results are expressed as the mean relative luciferase activity ± S.E.M. (from at least three independent experiments).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antibodies:</head><p><s>The antibodies against claudin-1, −2, −3, −4, and −7, were obtained from Invitrogen.</s><s>The Bcl-2, E-cadherin and β-Catenin antibodies were obtained from BD Biosciences (San Jose, CA) The P-27 and vimentin antibodies were purchased from Santa Crutz (CA) and the βactin and anti-α-SMA antibodies were from Sigma-Aldrich (MO).</s><s>Cyclin-D1, P-Stat3, Stat-3 and GSK3β antibodies purchased from Cell Signaling Inc. (MA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoblotting and immunohistochemistry:</head><p><s>The methods for immunoblotting and Immunohistochemical analysis have been described previously <ref type="bibr" target="#b54">(54)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Colon cancer patient mRNA analysis:</head><p><s>The protocols and procedures for the procurement of human tissue samples, details of the microarray platforms and statistical analysis have been described previously <ref type="bibr" target="#b19">(19)</ref>.</s><s>To compare the expression level of each probe between normal tissue, adenomas and different cancer stages, we employed Mann-Whitney test.     A. Quantitative representation of the proliferation/apoptosis ratio from immunohistochemical analysis of the serial sections of colon from WT and Cldn-3KO mice subjected to colon tumorigenesis, using Ki67 and cleaved caspase-3 expression as markers; B. Immunoblot analysis using colon lysate from WT and Cldn-3KO mice subjected to colon cancer and quantitative analysis of cyclin D1 and Bcl2 protein expression; C. Immunohistochemical analysis using anti β-catenin antibody; D. Immunoblot analysis using colon lysates from mice subjected to colon cancer and quantitative analysis of P-GSK-3β and β-catenin expression; E. Immunoblot analysis using control and Caco-2 siRNA cells.</s><s>F.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 :</head><label>1</label><figDesc><div><p><s>Figure 1: Claudin-3 expression associates positively with colonic epithelial differentiation and decreases sharply in colon tumors.</s><s>A. Endogenous expression of prominent cell adhesion proteins in mouse colon (n=6).</s><s>Data presented in the graph represent values after normalizing the band intensity for each protein to E-cadherin expression; B. Cartoon depicting normal organization of a colonic crypt and differentiation zone, and representative immunohistochemistry using anti-claudin-3 antibody; C. Immunoblot analysis using cell lysate from Caco-2 cells subjected to spontaneous differentiation, and D. NaB treatment; E. Immunoblot and quantitative analysis showing effect of global demethylation using 5-aza-2'-deoxycytidine upon claudin-3 and P-27 expressions in colon cancer cells.</s><s>F. Representative immunohistochemical analysis using APCmin mice colon (n=4) and anti-claudin-3 antibody; and G. Representative</s></p></div></figDesc><graphic coords="16,166.44,62.00,339.12,473.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 :</head><label>2</label><figDesc><div><p><s>Figure 2: Claudin-3 expression decreases in colon cancer in stage specific manner.</s><s>A. Claudin-3 transcriptome analysis using RNA isolated from colon cancer patients.</s><s>*P&gt;0.05</s><s>(normal versus adenoma) and ***P&gt;0.001</s><s>(normal versus all stages) (n=250); B and C. Representative immunohistochemical staining of spontaneous colon cancer [CRC; normal mucosa (n=10) (a), adenoma (n=5) (b), adenocarcinoma (n=20) (c) and lymph node metastasis (n=16) (d)] using anti-claudin-3 antibody and intensity score analysis of immunohistochemical staining of CRC samples ****P&gt;0.0001</s><s>(versus normal mucosa); D. Representative immunohistochemical staining of colitis associated cancer (CAC) using anticlaudin-3 antibody; E. Kaplan-Meir analysis to determine overall survival where red and blue colors indicate high and low claudin-3 expression, respectively.</s></p></div></figDesc><graphic coords="18,174.36,62.00,323.28,461.52" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 :</head><label>3</label><figDesc><div><p><s>Figure 3: Deletion (Genetic) of colonic claudin-3 expression induces colonic epithelial dedifferentiation and leaky gut, and promotes colon cancer burden.</s><s>A. FITC-dextran passes (4kDa) to determine mucosal permeability (at least 4 mice/group); B. Quantitative analysis of immune infiltration (CD3+ cells) into the mucosa (3 mice/group with at least 100 crypts/mice examined); C. Quantitative analysis of the immunoblot outcome using colon lysates from naïve Cldn-3KO and WT mice (4 mice/ group); D. Polyps numbers in Cldn-3KO (n#15) and littermate WT-mice (n#25) subjected to colon tumorigenesis and representative images of the colon from Cldn-3KO and WT-mice subjected to colon tumorigenesis; E. H&amp;E staining of the swiss-rolled colons; F. Graphical</s></p></div></figDesc><graphic coords="19,134.50,62.00,403.00,482.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 :</head><label>4</label><figDesc><div><p><s>Figure 4: Loss of colonic claudin-3 induces cancer invasiveness and promotes vimentin expression.</s><s>A. Colonic tumor scores in Cldn-3KO (n=15) and WT (n=25) mice (**p&lt;0.05);</s><s>B. A majority of the colon tumors in Cldn-3KO mice were invasive (Fisher exact test **p&lt;0.01</s><s>versus WT mice) and C. Representative H&amp;E staining showing invasive neoplasm in Cldn-3KO mice; D. Silencing of claudin-3 expression in colonic epithelial cells induces dedifferentiation: immunoblot analysis using cell lysates from control or claudin-3 siRNA transfected Caco-2 cells; E. Effect of siRNA silencing of claudin-3 expression upon cell mobility and cell invasion; F. Spearman's correlation analysis of colon cancer patient microarray data to determine association between claudin-3 and vimentin expressions; and G. Representative co-immunofluorescence analysis using AOM/DSS-treated mice colon, anti-claudin-3 (red) and vimentin (green) antibody (n=3 and 15 high power field (20x)/mice was used for determination.</s><s>Values are mean ± S.E.M. *p&lt;0.05,</s><s>**p&lt;0.01</s><s>versus control.</s></p></div></figDesc><graphic coords="21,116.76,62.00,438.48,325.26" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 :</head><label>5</label><figDesc><div><p><s>Figure 5: Increased intratumoral proliferation and hyperactivation of the Wnt/β-catenin and IL-6/Stat-3 signaling characterize tumors in Cldn-3KO mice.</s></p></div></figDesc><graphic coords="22,170.40,62.00,331.20,476.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 6 :</head><label>6</label><figDesc><div><p><s>Figure 6: Claudin-3 loss induces IL6/gp130/Stat-3 dependent activation of the Wnt/β-catenin signaling.</s><s>A. Co-immunofluorescence analysis of β-catenin and claudin-3 in control or anti-claudin-3 siRNA transfected cells and in response to IL-6 treatment alone or in combination with Nicosolamide; B. TOP-FLASH reporter activity using control and claudin-3 siRNA transfected cells.</s><s>S33Y transfected cells served as positive control; C. Effect of IL-6 treatment upon Stat-3 phosphorylation and cyclin D1 expression in control and claudin-3 siRNA transfected cells; D. TOP-FLASH reporter activity in control and claudin-3 siRNA transfected cells subjected to niclosamide treatment; E. mRNA expression analysis of Wnt-signaling targets cyclin-D1 and C-myc; F. Cartoon depicting how loss of colonic</s></p></div></figDesc><graphic coords="24,168.00,62.00,336.00,470.88" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Oncogene. Author manuscript; available in PMC 2019May 13.   </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowlegement:</head><p><s>This work was supported by BX002086 (P.D.), DK088902 and BX002761 (A.B.S.).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Colon permeability measurements:</head><p><s>To determine the potential changes in colonic permeability, FITC-dextran (4 kDa) was used, as described previously (Please see Supplementary Information) <ref type="bibr" target="#b54">(54)</ref>.</s><s>Presence of the dye in the blood was assessed in samples collected before (0 h) and 30 min after FITC-dextran administration.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Induction of colonic epithelial differentiation:</head><p><s>Caco-2 cells undergo spontaneous differentiation when cultured over an extended period <ref type="bibr" target="#b14">(14)</ref>.</s><s>Accordingly, 1×10 6 cells were plated in 6-well dishes and culture medium was changed every second day.</s><s>Cells were harvested to prepare lysate at indicated times.</s><s>Alternatively, cells were treated with sodium butyrate (NaB), a histone deacetylase inhibitor, using indicated concentrations.</s><s>Of note, NaB induces differentiation among cancer cells <ref type="bibr" target="#b56">(56)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis:</head><p><s>Data were analyzed with Graph Pad Prism Version 6.0 software and are presented as mean ± SEM.</s><s>Statistical analysis was performed by Student's t test, 1-way ANOVA analysis of variance and Fisher's exact test.</s><s>The Kaplan-Meier curve was used for survival analysis and Spearman's correlation analysis was done to analyze the association between variables.</s><s>P value of less than 0.05 was considered significant.</s><s>*P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.005.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Absence of Claudin-3 protein and its mRNA transcript in Cldn-3KO mice was confirmed using Western blotting, immunohistochemistry and real-time quantitative PCR (Supplementary Fig. S4A-B and Fig. 5G). All animal experiments were performed according to institutional guidelines</title>
		<imprint/>
	</monogr>
	<note>Claudin-3 knockout mice: Generation of Cldn-3KO mice was recently described (55)</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Grivennikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mucida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schnabl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jauch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="issue">7423</biblScope>
			<biblScope unit="page" from="254" to="258" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23034650</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Grivennikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Karin</forename><forename type="middle">E</forename><surname>Terzic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mucida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Vallabhapurapu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Cell</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="103" to="113" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19185845</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Increased tight junctional permeability is associated with the development of colon cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Soler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Laughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Z</forename><surname>Carp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Klurfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mullin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1425" to="1431" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>PubMed: 10426787</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Epidermal growth factor-induced mitogenesis in kidney epithelial cells (LLC-PK1)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mullin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Mcginn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="4886" to="4891" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note>PubMed: 3261628</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Effects of diacylglycerols on LLC-PK1 renal epithelia: similarity to phorbol ester tumor promoters</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mullin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Mcginn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">3127401</biblScope>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Claudins and cancer: Fall of the soldiers entrusted to protect the gate and keep the barrier intact. Seminars in cell &amp; developmental biology</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dhawan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Activation of betacatenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Sparks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Korinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Clevers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vogelstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">5307</biblScope>
			<biblScope unit="page" from="1787" to="1790" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>PubMed: 9065402</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">WNT signalling pathways as therapeutic targets in cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Anastas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Moon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="26" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23258168</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Van Itallie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Expr Patterns</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="581" to="588" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16458081</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fortunato-Miranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Robbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>De Araujo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>De-Freitas-Junior</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Bastos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e74994</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24069372</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium</title>
		<author>
			<persName><forename type="first">H</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Crean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">W</forename><surname>Cummings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Gabig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">21</biblScope>
			<biblScope unit="page" from="7878" to="7881" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11691807</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Epithelial cell polarity: a major gatekeeper against cancer?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Royer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Differ</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1470" to="1477" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21617693</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Tight junction and polarity interaction in the transporting epithelial phenotype</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cereijido</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Contreras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Shoshani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Flores-Benitez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Larre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1778</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="770" to="793" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18028872</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2</title>
		<author>
			<persName><forename type="first">H</forename><surname>Matsumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Erickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshioka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1199" to="1207" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note>Pt 1. PubMed: 2323513</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Changes in the cellular behaviour of human colonic cell line Caco-2 in response to butyrate treatment</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Dzierzewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Orchel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Weglarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Latocha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wilczok</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Biochim Pol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="211" to="220" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>PubMed: 12136943</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Role of p27(Kip1) in human intestinal cell differentiation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Deschenes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vezina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Beaulieu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rivard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="423" to="438" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>PubMed: 11159883</note>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Smooth muscle actin expression during rat gut development and induction in fetal skin fibroblastic cells associated with intestinal embryonic epithelium. Differentiation; research in biological diversity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kedinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Simon-Assmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bouziges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Alexandre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Haffen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1990">1990</date>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="87" to="97" />
		</imprint>
	</monogr>
	<note>PubMed: 2197142</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Characterization of HCT116 human colon cancer cells in an orthotopic model</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rajput</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dominguez San Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Levea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sharratt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">The Journal of surgical research</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="276" to="281" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17961596</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dhawan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Deane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>No</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Shiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1765" to="1776" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15965503</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Epigenetics of cancer progression</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Vucic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Lam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacogenomics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="215" to="234" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18370850</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">Regulation of the CLDN3 gene in ovarian cancer cells. Cancer biology &amp; therapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Honda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Pazin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Ji</forename><forename type="middle">H</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1733" to="1742" />
		</imprint>
	</monogr>
	<note>PubMed: 17986852</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">ApcMin: a mouse model for intestinal and mammary tumorigenesis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Luongo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Gould</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Mcneley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Shoemaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Dove</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">European journal of cancer</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">7-8</biblScope>
			<biblScope unit="page" from="1061" to="1064" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>PubMed: 7576992</note>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS)</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Thaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ciorba</surname></persName>
		</author>
		<idno>JoVE. 2012</idno>
		<imprint/>
	</monogr>
	<note>Journal of visualized experiments</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dhawan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chaturvedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Midha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Mittal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">29</biblScope>
			<biblScope unit="page" from="3234" to="3247" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21383692</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Bhat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Pope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Washington</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">35</biblScope>
			<biblScope unit="page" from="4570" to="4580" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25500541</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Epidermal growth factor receptor inhibits colitis-associated cancer in mice</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Punit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Girish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Mcelroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Washington</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2780" to="2792" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22772467</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Ngan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Seshimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsujino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Man-I</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Ikeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="986" to="992" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17325702</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Nagaraja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Othman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Alsaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Pellegrino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zeng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="2328" to="2338" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16314837</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">D</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="7663" to="7676" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25277196</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 betadependent phosphorylation of beta-catenin and down-regulates beta-catenin</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hinoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Takada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kikuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page" from="34399" to="34406" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 10906131</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Caught up in a Wnt storm: Wnt signaling in cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Giles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Van Es</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Clevers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochimica et Biophysica Acta (BBA) -Reviews on Cancer</title>
		<imprint>
			<biblScope unit="volume">1653</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="24" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12781368</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Inhibition of β-Catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-Catenin/TCF-1 complex: Critical role of STAT-3</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Pramanik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Fofaria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ranjan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Srivastava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="11561" to="11574" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25869100</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Insertional Mutagenesis Identifies a STAT3/Arid1b/beta-catenin Pathway Driving Neurofibroma Initiation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">W</forename><surname>Keng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Patmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kendall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jousma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1979" to="1990" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26904939</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Tenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ordonez-Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Puig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Chicote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Arques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Landolfi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="892" to="901" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22610277</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">beta-Catenin signaling in biological control and cancer</title>
		<author>
			<persName><forename type="first">N</forename><surname>Gavert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ben-Ze'ev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="820" to="828" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17854061</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">STATs in cancer inflammation and immunity: a leading role for STAT3</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pardoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jove</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="798" to="809" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19851315</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Inhibition of beta-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear beta-catenin/TCF-1 complex: critical role of STAT-3</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Pramanik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Fofaria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ranjan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Srivastava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="11561" to="11574" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25869100</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Heinzelmann-Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gardiner-Garden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Henshall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scurry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Scolyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Davies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clinical cancer research : an official journal of the American Association for Cancer Research</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="4427" to="4436" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma. Diagnostic pathology</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Bartholow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">R</forename><surname>Chandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Becich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Parwani</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">12</biblScope>
		</imprint>
	</monogr>
	<note>PubMed: 21255442</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">PI3K/Akt and GSK-3beta prevents in a differential fashion the malignant phenotype of colorectal cancer cells</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>De Araujo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>De Freitas</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>De Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Morgado-Diaz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cancer Res Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1773" to="1782" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20204404</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Balch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="974" to="983" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20053926</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness</title>
		<author>
			<persName><forename type="first">A</forename><surname>Yaqinuddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Qureshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Qazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Farooq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Abbas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Urol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="756" to="761" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19539327</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Claudins and cancer: Fall of the soldiers entrusted to protect the gate and keep the barrier intact</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dhawan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Cell Dev Biol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="58" to="65" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26025580</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Myers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Kurundkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maheshwari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nusrat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="626" to="635" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22155109</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Dietary methionine restriction improves colon tight junction barrier function and alters claudin expression pattern</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ramalingam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gabello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Valenzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Soler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">299</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="C1028" to="1035" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20739626</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rosenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Bergstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Valdez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Microbiol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="388" to="403" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17910742</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Doelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Halpern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Holubec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dvorak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Gastrointest Liver Physiol</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="G938" to="949" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16798726</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation</title>
		<author>
			<persName><forename type="first">N</forename><surname>Turgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Blais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gagne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Tardif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Boudreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Perreault</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e73785</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24040068</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stability</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Quinley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herdman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">287</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="18182" to="18189" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22496368</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Activation of the signal transducer and transcription (STAT) signaling pathway in a primary T cell response. Critical role for IL-6</title>
		<author>
			<persName><forename type="first">T</forename><surname>Henttinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Silvennoinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hurme</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4582" to="4587" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>PubMed: 7594456</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Epithelial barriers, compartmentation, and cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mullin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci STKE</title>
		<imprint>
			<biblScope unit="issue">216</biblScope>
			<biblScope unit="page">e2</biblScope>
			<date type="published" when="2004">2004. 2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 14734784</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Finnerty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Herndon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Brasier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1212" to="1220" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23303450</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing</title>
		<author>
			<persName><forename type="first">Tadlaoui</forename><surname>Hbibi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Laguillier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Souissi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lesage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Le</forename><surname>Coquil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS J</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2505" to="2515" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19476491</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chaturvedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Olivares-Villagomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Habib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Asim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shivesh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mucosal Immunol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1340" to="1353" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24670427</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kooij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kopplin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blasig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stuiver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Koning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Goverse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="267" to="277" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24356983</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability</title>
		<author>
			<persName><forename type="first">M</forename><surname>Krishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Eschrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="305" to="312" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 19881542</note>
</biblStruct>

<biblStruct xml:id="b57">
	<monogr>
		<title level="m" type="main">Immunoblot analysis using colon lysates from Cldn-3KO and WT-mice subjected to colon tumorigenesis and quantitative analysis of Phospho-stat-3 expression relative to stat-3 levels</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">PCR using mRNA isolated from mice colon subjected to colon carcinogenesis (n=3 mice/group). Values are mean ± S.E.M. *p&lt;0.05, **p&lt;0.01 versus WT mice. claudin-3 expression can modulate molecular and signaling events to promote CRC progression. Values are mean ±</title>
		<author>
			<persName><forename type="first">G</forename><surname>Qrt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">S.E.M</title>
		<imprint/>
	</monogr>
	<note>*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
